All lobbying filings
Ballard Partners
Ballard Partners filed a Q1 report for Madrigal Pharmaceuticals, Inc. on April 16, 2026, reporting $120,000 in lobbying income.
Lobbying for Madrigal Pharmaceuticals, Inc. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 16, 2026
Income
$120,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Lobbyists on this filing
1
-
ALISON ANWAYPreviously held: LA to Senator Pat Roberts 2006-2010
Government bodies contacted
2
Lobbying activity
1
Advocacy related to prescription drug access and pricing.